Matt Noestheden

What to expect for cannabis in 2022 and beyond

Feb 1, 2022 | Blogs, Cannabis, Food / Beverage, Food and Beverage | 0 comments

Read time: 2 minutes

As the new year commences and we make plans for 2022, cannabis will be a hot topic in some areas of the world. There may be continuations from 2021 around legislations and regulations, and we might even see new trends for some regions and countries.

Legalization of recreational cannabis in Germany

Let’s first discuss the news that is at the top of my list: legalization of cannabis for recreational use in Germany. In December 2021, Germany welcomed a new chancellor, Olaf Scholz, who has several plans on his agenda, including legalizing cannabis.¹ Currently, it is not illegal to consume cannabis, but it is to buy it. This would make Germany the first major European country to legalize recreational marijuana.²

The parties in the new coalition government agreed to legalize the sale of cannabis to adults if it is sold in licensed establishments where it is properly taxed and quality controlled. Some believe this move will allow Germany to “have a regulated and taxed dispensary, controllable quality and effective youth protection through education.”² However, some of the other parties are not in favor of this. For example, Markus Blume, the party secretary of the CSU, believes it will make a “harmful” drug into a “lifestyle product,” and according to a study, 59% of people say it would be better left the way it has been since 2011.²

Although we can’t say for certain that Olaf Scholz will implement this decision, it will be a hot topic in this year’s cannabis news, so watch for updates.

Cannabis in the US

For most of human history, until the early 20th century, cannabis use was legal in the US. Between 1916 and 1931, however, 29 US states banned the use of marijuana.³ Then came the Marihuana Tax Act of 1937, which was influenced by the Federal Bureau of Narcotics Commissioner at the time, Harry Anslinger and essentially made cannabis illegal across the US.⁴

When we look at the legislation in place today, we can see the legalization of cannabis has started to come full circle across the US. As of July 2021, cannabis had been legalized for recreational use in 18 states and approved for medical use in 37 states.⁵ Given this groundswell of support for medical and recreational cannabis use, might 2022 bring a federal move to legalization? Let’s take a look.

Back in September 2021, a key committee in the US House of Representatives approved a bill to federally legalize marijuana with an aim of promoting social equity.⁶ While federal cannabis legalization does not appear to be a priority for the Biden administration, efforts continue in the House and the US Senate to bring federal policy closer in line with state laws. With these efforts ongoing, and with 60% of adults believing that cannabis should be legal for both medical and recreational use⁷, might 2022 be the year we see federal legalization?

References

Kirby, J. Germany’s new government has big plans. It might be a shock after Merkel. Vox, December 8, 2021. https://www.vox.com/2021/12/8/22810520/germany-government-olaf-scholz-chancellor-greens-fdp
Schuetze, C.F. The new German government plans to legalize Cannabis. The New York Times, November 24, 2021. https://www.nytimes.com/2021/11/24/world/europe/german-government-cannabis.html
Speights, K. A Guide to Marijuana Legalization in the United States. The Motley Fool, November 29, 2021. https://www.fool.com/investing/stock-market/market-sectors/healthcare/marijuana-stocks/marijuana-legalization/
US Customs and Border Protection: Did You Know… Marijuana Was Once a Legal Cross-Border Import? Last modified December 20, 2019. https://www.cbp.gov/about/history/did-you-know/marijuana
Hupka, S. Senate moves to legalize pot at federal level. What are the chances? Los Angeles Times, July 29, 2021. https://www.latimes.com/politics/story/2021-07-29/what-are-the-chances-senate-will-legalize-pot-marijuana
Jaeger, K. Bill To Federally Legalize Marijuana Approved By Key House Committee. Marijuana Moment, September 30, 2021. https://www.marijuanamoment.net/watch-live-key-house-committee-to-vote-on-federal-marijuana-legalization-bill/
Malyshev, A.; Ganley, S. Reading the tea leaves: What might federal legalization of marijuana look like? Reuters, November 15, 2021. https://www.reuters.com/legal/litigation/reading-tea-leaves-what-might-federal-legalization-marijuana-look-like-2021-11-15/

RUO-MKT-18-14262-A

Why traditional MS/MS falls short for ADCs and how electron-activated dissociation (EAD) changes the equation

Antibody-drug conjugates (ADCs) are among the most promising—and analytically demanding—modalities in biopharma today. By combining large, heterogeneous antibodies with chemically labile payloads and linkers, ADCs introduce a level of structural complexity that challenges conventional analytical workflows. It also poses the challenge that the very features you need to measure are often the easiest to lose during analysis.

Six benefits of remote support every laboratory should know

Imagine having a tech expert at your fingertips to solve computer issues or a fitness trainer guiding you through workouts from the comfort of your home. In today’s fast-paced world, the ability to provide and receive service and support remotely is no longer a luxury but a necessity. Whether it’s troubleshooting a software issue, repairing a device, offering customer assistance, or enjoying the convenience of telehealth as a private individual, remote capabilities have revolutionized how businesses operate and how individuals get help

The costly consequences of unplanned downtime

Unplanned downtime is a formidable adversary that businesses across various industries strive to minimize. Defined as the unexpected interruption of regular operations, unplanned downtime can wreak havoc on productivity, profitability and customer satisfaction. In this article, we delve into the causes of unplanned downtime, its far-reaching consequences and strategies to mitigate its impact.

Posted by

Matt Noestheden

Matt is the Market Development Manager for the Cannabis, Food and Environmental markets in the Americas at SCIEX. Matt brings 15 years of LC-MS experience to this role, spanning the pharmaceutical, environmental, food and cannabis industries. Matt loves talking about all things mass spectrometry, so reach out if you have any questions at matt.noestheden@sciex.com.

0 Comments